Stay Up To Date

Latest News

Latest blogs, press releases, and reports from P4ADNOW.

Latest News | Apr 17, 2026

The Week in Review in Prescription Drug Pricing: Medicare Negotiation Round 3 Drugs and ORPHAN’s Impact, Healthcare Costs Top Worry for Americans, and more

Latest News | Apr 10, 2026

The Week in Review in Prescription Drug Pricing: TrumpRx adds Humira, Pharma Threatens CO’s PDAB, Ubl Out, P4AD Expands, and more

Latest News | Apr 3, 2026

The Week in Review in Prescription Drug Pricing: 100% Tariffs Are Back, Admin Admits MFN Deals Won’t Lower U.S. Prices, Americans Want Generic Options

Latest News | Mar 27, 2026

The Week in Review in Prescription Drug Pricing: New Analysis, FTC Settles Second PBM Case, Merck Acquisitions as Keytruda Patent Cliff Approaches, and more

Latest News | Mar 20, 2026

The Week in Review in Prescription Drug Pricing: New Analysis, TrumpRx Claims Fall Flat, GSK Exploits Medicaid Loophole, and more

Latest News | Mar 13, 2026

The Week in Review in Prescription Drug Pricing: Healthcare Costs Force Life Delays, Ozempic & Wegovy for $3, FDA Biosimilar Moves, and more

Latest News | Mar 6, 2026

The Week in Review in Prescription Drug Pricing: TrumpRx MFN Deals Are Designed to Run Out, and GENEROUS Model Deadline Extended

Latest News | Feb 27, 2026

The Week in Review in Prescription Drug Pricing: P4AD on GLOBE & GUARD, the State of Drug Pricing, and Novo News